ReviewTaiwan journal of ophthalmology
Dacryoendoscopy: Historical development, philosophical foundation, and clinical perspective.
Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dacryoendoscopy is valuable for managing epiphora, enabling direct visualization of the lacrimal outflow system. Notably, dacryoendoscopy enhances diagnostic precision and facilitates minimally invasive treatment. Over the past three decades, its evolution has fostered a deeper understanding of endoluminal pathology, refined recanalization techniques, and expanded therapeutic indications across age groups. Importantly, dacryoendoscopy represents not only technical refinement but also a conceptual shift - from blind intervention to anatomy-based diagnosis and management. This shift reflects a deeper surgical philosophy, that visualization must precede intervention, and that humility toward unseen structures is crucial for true minimally invasive practice. This narrative review explores the device design philosophy, terminology, and clinical use of dacryoendoscopy, focusing on the Bent group's contributions and the emergence of conservative minimally invasive lacrimal surgery, which emphasizes mucosal preservation and is specifically suited for pediatric cases. The Bent probe endoscopes, originating in Japan, have become the most widely used devices in Asia. Moreover, false passage was illustrated in relation to the duct lumen remnant within fibrous blockage, and key techniques, including sheath-guided endoscopic probing and sheath-guided intubation, were reviewed. Regardless of these advances, challenges such as long-term deterioration of surgical outcomes and the distant goal of mucosal regeneration persist. Relevant literature was identified through a nonsystematic search of PubMed and Ichushi-Web, using the keywords "dacryoendoscopy," "nasolacrimal duct," and "false passage," covering publications from 1995 to 2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.